Carl Pechstein's Page

THIS UNKNOWN GEM IS THE CHEAPEST STOCK WITH THE HIGHEST UPSIDE POTENTIAL IN THE COMPLETE BIOTECH SECTOR .DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL ! GLTA This Goldmine has a VERY LOW burn-rate of only $1.2 M a year means we have enuff cash untill 2014 EXCLUDING cpi-300 revenue and EXCLUDING upfront payments from upcoming partnerships BUT MORE IMPORTANT TO KNOW IS THAT WE WILL REACH PROFITABILITY THIS YEAR !!! 2x NDA filings for Migraine and Antipsychotic drugs this year which…See More

IPCI IS THE BEST AND THE MOST UNDERVALUED UNKNOWN GEM IN THE BIOTECH SECTOR BUT PLEASE DO YOUR OWN RESEARCH ! GLTAThis Unknown ULTRA LOW FLOAT Stock awaiting 6 FDA approvals.IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .Market Cap 48 Mil / Cash 7.5 M / Burn-rate 4.5 M per Year = Enough Cash until Profitability which will happen THIS YEAR .4x FDA APPROVALS IN 2012 = $10++ EASILY FOLKS !!!Intellipharmaceutics (IPCI)Market Cap:$ 48 MCash: $ 7.5…See More

This Goldmine currently trades below cash but this will change with the upcoming FDA Decision on 14th Feb . FDA approval will push this wayyy oversold goldmine back to $1.50++ easily . BPAX will get $5 Mil upon FDA approval and 10% royalties from partner TEVA Pharma . Buy now and make a lot of money with the runup to Fda decision folks . Biosante (BPAX) Market cap : $71 M Cash : $ 70 M Price: 0.65 MEGA PIPELINE…See More

THIS UNKNOWN GEM IS THE CHEAPEST STOCK WITH THE HIGHEST UPSIDE POTENTIAL IN THE COMPLETE BIOTECH SECTOR .DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL ! GLTA This Goldmine has a VERY LOW burn-rate of only $1.2 M a year means we have enuff cash untill 2014 EXCLUDING cpi-300 revenue and EXCLUDING upfront payments from upcoming partnerships BUT MORE IMPORTANT TO KNOW IS THAT WE WILL REACH PROFITABILITY THIS YEAR !!! 2x NDA filings for Migraine and Antipsychotic drugs this year which…See More

This LOW FLOAT MONSTER trading BELOW CASH and awaiting FDA approval within 45 days . Qutenza is already approved for another indication thats why it has a very high chance for FDA approval . This low float sleeping giant is almost unknown to the most investors means the stock will explode once the investor discover this low float monster . Anesthetic and Analgesic Drug Products Advisory Committee Meeting Scheduled for February 9, 2012 NeurogesX announced the FDA acceptance of the sNDA filing…See More

This Goldmine currently trades below cash but this will change with the upcoming FDA Decision on 14th Feb . FDA approval will push this wayyy oversold goldmine back to $2++ easily ..Buy now and make a lot of money with the runup to Fda decision folks .TARGET 3-5 dollar in 2012 ! GLTABiosante (BPAX)Market cap : $56 MCash : $ 70 MPrice: 0.515MEGA PIPELINEhttp://www.biosantepharma.com/Products.phpBio-T-Gel™Bio-T-Gel™ is a once-daily…See More

FDA approval will push this stock to $5++ easily because ADASUVE has HUGE sales potential . Get in NOW and make some quick profits then sell before the Meeting IF you are a weaky or hold trough the meeting if you are a stronger shareholder ... RUNUP will bring this back near $2 .....GL Alexza Pharma (ALXA) Market Cap: 76.4 M Cash: 28.3 M Price: 1.07 On October 24, 2011, Alexza announced that the FDA has scheduled a meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) for…See More

A NEW TEVA IS IN THE MAKING HERE FOLKS....PATIENCE IS ALL YOU NEED TO GET RICH WITH THIS ONE !!!! GLTAThis low float sleeping giant awaiting 6 FDA approvals .IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .Burn-rate is only 1.5 M per Q means enuff till 2013 EXCLUDING upfront payments from Upcoming Partnerships . IPCI will be profitable in 2012 !!!CEO is the largest Shareholder of this unknown Goldmine with over 6 M shares .First FDA approval and new…See More